Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

SHE:002099 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,743	1,517	1,421	1,491	1,828	1,970
Trading Asset Securities	19.43	45.03	-	-	9.48	-
Cash & Short-Term Investments	1,762	1,562	1,421	1,491	1,837	1,970
Cash Growth	10.41%	9.96%	-4.71%	-18.86%	-6.72%	26.54%
Accounts Receivable	489.19	460.09	445.14	541.38	521.07	447.66
Other Receivables	7.26	7.01	10.3	42.9	56.48	9.38
Receivables	496.45	467.09	455.44	584.28	577.54	457.04
Inventory	795.68	799.71	702.27	1,102	907.97	727.41
Other Current Assets	69.16	61.9	47.45	68.15	114	85.71
Total Current Assets	3,124	2,891	2,626	3,246	3,437	3,240
Property, Plant & Equipment	2,876	2,961	3,029	3,098	2,981	2,562
Long-Term Investments	637.32	638.44	671.67	720.88	259.42	47.88
Goodwill	394.84	394.84	603.31	711.01	757.74	757.74
Other Intangible Assets	515.48	520.43	520.8	555.76	490.13	517.88
Long-Term Deferred Tax Assets	36.92	42.56	41.57	52.34	52.18	42.18
Long-Term Deferred Charges	2.63	2.8	4.04	2.06	2.52	1.4
Other Long-Term Assets	6.47	5.55	23.65	7.81	39.82	10.08
Total Assets	7,593	7,456	7,520	8,393	8,020	7,179
Accounts Payable	722.18	862.1	603.34	995.04	1,029	613.25
Accrued Expenses	35.16	82.87	81.61	81.72	88.24	97.89
Short-Term Debt	1,516	1,222	1,030	833.81	571.93	430.79
Current Portion of Long-Term Debt	5.32	-	10.01	2	-	-
Current Portion of Leases	-	5.26	4.46	3.84	3.82	-
Current Income Taxes Payable	24.27	9.4	5.06	3.42	9.52	6.11
Current Unearned Revenue	13.92	12.67	10.13	8.16	9.7	10.82
Other Current Liabilities	45	34.12	62.03	42.69	20.72	22.89
Total Current Liabilities	2,362	2,228	1,807	1,971	1,733	1,182
Long-Term Debt	-	-	-	148.14	-	-
Long-Term Leases	6.36	6.62	10.21	14.01	17.82	-
Long-Term Unearned Revenue	51.72	54.4	57.31	54.44	53.45	48.33
Long-Term Deferred Tax Liabilities	31.13	33.57	41.34	99.58	101.03	94.09
Other Long-Term Liabilities	1.33	1.33	2.68	1.33	1.33	2.33
Total Liabilities	2,453	2,324	1,918	2,288	1,906	1,326
Common Stock	1,619	1,619	1,619	1,619	1,619	1,619
Additional Paid-In Capital	2,917	2,917	2,906	2,906	2,844	2,643
Retained Earnings	758.37	749.14	1,079	1,580	1,654	1,591
Treasury Stock	-151.42	-151.42	-	-	-	-
Comprehensive Income & Other	5.78	5.78	1.95	2.59	-1.64	-1.34
Total Common Equity	5,148	5,139	5,606	6,108	6,115	5,852
Minority Interest	-8.16	-7.24	-4.63	-3.06	-1.38	-0.02
Shareholders' Equity	5,140	5,132	5,602	6,105	6,114	5,852
Total Liabilities & Equity	7,593	7,456	7,520	8,393	8,020	7,179
Total Debt	1,528	1,234	1,055	1,002	593.57	430.79
Net Cash (Debt)	234.18	328.28	365.71	489.02	1,244	1,539
Net Cash Growth	-8.77%	-10.23%	-25.22%	-60.69%	-19.17%	13.49%
Net Cash Per Share	0.17	0.21	0.23	0.28	0.78	0.96
Filing Date Shares Outstanding	1,587	1,587	1,619	1,619	1,619	1,619
Total Common Shares Outstanding	1,587	1,587	1,619	1,619	1,619	1,619
Working Capital	761.29	662.46	818.91	1,275	1,704	2,058
Book Value Per Share	3.24	3.24	3.46	3.77	3.78	3.62
Tangible Book Value	4,238	4,224	4,482	4,841	4,867	4,576
Tangible Book Value Per Share	2.67	2.66	2.77	2.99	3.01	2.83
Buildings	-	1,692	1,699	1,514	1,304	1,196
Machinery	-	3,168	3,146	3,025	2,610	2,210
Construction In Progress	-	564.58	372.91	449.12	670.81	568.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.